Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene

NCT03328130 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class

Stopped lack of financing

Conditions

Interventions

Sponsor

eyeDNA Therapeutics